Dove Medical Press
Doris Benbrook has a diverse work experience spanning over several decades. Doris started their career as a Postdoctoral Fellow at the Sanford-Burnham Medical Research Institute in 1985. Following this, they worked as a Research Fellow at Cancer Research UK from 1988 to 1991. In 1991, they joined the University of Oklahoma Health Sciences Center as a Professor and Co-Director of the Center for Cancer Prevention and Drug Development. Simultaneously, they also owned their own business. Doris later became an Editor-in-Chief for the Journal of Biologics, Targets & Therapy in 2008. Doris has also worked as a Grant Reviewer for the National Institutes of Health and as a Consultant for Procter & Gamble. In 2012, they served as a Scientific Expert Witness at Haynes and Boone, LLP, where they provided scientific expertise for legal cases.
Doris Benbrook obtained their Bachelor's degree in Biology and Chemistry, with a minor in German, from North Central College. Doris attended this institution from 1977 to 1981. Following this, they pursued further education at Loyola University Chicago Stritch School of Medicine, where they earned their PhD in Biochemistry. Doris'sdoctoral studies took place between the years 1981 and 1985.
This person is not in any offices
Dove Medical Press
Dove Medical Press Ltd is an online open access academic publisher specialising in science, technology and especially medicine. All 80+ peer-reviewed journals are free to access online, allowing authors to disseminate their research to a global audience. Most of our journals are widely indexed in databases such as PubMed, Scopus and DOAJ, and an increasing number have Impact Factors. We are a member of OASPA, COPE and HINARI, and are committed to publishing good scientific research and giving authors around the world the opportunity to publish and share their research findings. We have an efficient and rigorous peer-review process. Due to this, many of our journals are able to provide authors with an initial editorial decision within four to five weeks. We aim to provide the highest possible standard of service to our authors. Recent feedback from an author survey demonstrated that: • 100% of authors surveyed found the online manuscript system easy to use • 100% of authors surveyed agreed that they received professional accurate service • 97% of authors surveyed would submit a manuscript with us again • 96% of authors surveyed received prompt communication throughout the publishing process • 86% of authors surveyed rated their level of satisfaction as Excellent (the other 14% rated us as good) To view testimonials from more of our authors please visit: https://www.dovepress.com/testimonials.php We have offices in the United Kingdom, USA and New Zealand. Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC